Remove industry-perspectives-sponsored
article thumbnail

Rethinking trial engagement and recruitment starts with patient perspectives: patient survey insights

pharmaphorum

It’s through that sharp lens that the pharma industry also saw an all-time high in consumer interest in clinical research during the pandemic. Leveraging patient perspectives. respondents and a third of EU respondents reported that their trust in clinical research and the pharma industry had increased since the start of the pandemic.

article thumbnail

Medical device manufacturers must remain “vigilant” to ensure data integrity of premarket submissions

European Pharmaceutical Review

It advised manufacturers and study sponsors for these products to “carefully evaluate the third parties they engage to conduct performance testing and to independently verify all testing results before submitting to the FDA.” This was communicated in a Letter to Industry (medical devices) published by the agency on 20 February 2024.

FDA 85
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key operational considerations to optimise decentralised clinical trials

pharmaphorum

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly helping to address long-standing issues in research and development for sponsors, study teams and, most importantly, patients.

article thumbnail

Frontiers Steering Committee spotlight: Megan Coder

pharmaphorum

The conversation in 2017-2018 era was much more focused on is clinical evidence valuable, how do we actually define industry, how do we talk about these products and how do we start to look at them in the context of care?” Prioritising patient perspectives. Bringing the industry together.

95
article thumbnail

Five for Friday February 9: Celebrating Success in Advancing Medication Use Quality

PQA

Enhance the impact of your attendance by becoming a sponsor of the meeting. We also highlight our members' perspectives on patient reported outcomes, pharmacy consultation and pharmacy care management services. Review these opportunities in the Sponsorship Prospectus, learn more below and connect with me.

59
article thumbnail

Legal requirement, ethical duty: How to develop compliant, useful lay summaries

pharmaphorum

New lay summary guidelines walk sponsors through their obligations under EU regulation No. That was among the key messages from speakers at a joint European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) webinar, held last week. The patient perspective.

article thumbnail

Engaging change: Connecting patients and regulators can move the dial on drug development

pharmaphorum

“It’s important that the patient experience and patient voice is appropriately elevated, and that regulators, sponsors, and researchers are meaningfully engaging patient stakeholders in order to define the most high-value areas of impact.”.

FDA 105